| Putting the 'Test' in Test and Treat: Thinking About HIV Testing in 2012 |  | 
|  |
| HIV Testing in a Test and Treat Era |  | 
|  |
| The National HIV/AIDS Strategy |  | 
|  |
| The San Francisco Epidemic |  | 
|  |
| HIV Testing in San Francisco |  | 
|  |
| More Frequent Testing, More Acute Infections |  | 
|  |
| Diagnosing Early HIV Infection |  | 
|  |
| Late HIV Diagnosis in San Francisco: SFDPH Surveillance, 2009-2010 |  | 
|  |
| Seeking the Untested HIV+ |  | 
|  |
| Where is Testing Going in 2012? |  | 
|  |
| Bold model - Universal HIV testing, Immediate Treatment, Eliminate HIV |  | 
|  |
| Early ART and Prevention in SF |  | 
|  |
| Early ART and Prevention in SF |  | 
|  |
| Acute HIV and Sexual HIV Transmission |  | 
|  |
| Early ART and Prevention in SF |  | 
|  |
| Acute HIV and Sexual HIV Transmission |  | 
|  |
| Acute HIV and Sexual HIV Transmission |  | 
|  |
| Acute HIV and Sexual HIV Transmission |  | 
|  |
| Acute HIV and Sexual HIV Transmission |  | 
|  |
| HIV Spreads in Sexual Networks |  | 
|  |
| HIV Spreads in Sexual Networks |  | 
|  |
| HIV Spreads in Sexual Networks |  | 
|  |
| HIV Spreads in Sexual Networks |  | 
|  |
| Contribution of Acute HIV Transmission Depends on Epidemic Stage |  | 
|  |
| Epidemiologic Linkages Using Phylogenetic Analysis: Quebec |  | 
|  |
| The Post Test-and-Treat World |  | 
|  |
| Recognition of Outbreaks = Acute Case Identification = Opportunities for Intervention |  | 
|  |
| Shifts in CDC Testing Policy |  | 
|  |
| Imminent CDC Policy Shifts |  | 
|  |
| Sensitivity of HIV Assays for 54 RNA + Acute Cases (n=21,234, SFDPH Sites 2004-8) |  | 
|  |
| AMPLIAR Study 010: a Prospective Trial of Rapid Results Acute HIV Testing |  | 
|  |
| Recent HIV Infection Staging Tests? |  | 
|  |
| Western Blot and Individual Staging |  | 
|  |
| New Supplemental Tests to Replace IFA and WB in 2012 CDC Algorithms |  | 
|  |
| Biorad Geenius(TM) System |  | 
|  |
| AMPLIAR Study 020: Evolution of gp160 Reflectance over Time (n=23) |  | 
|  |
| Advantages of RTs for Clinical Staging |  | 
|  |
| Pitfalls of RTs for Clinical Staging and Surveillance Uses |  | 
|  |
| DPP Preliminary Performance for Individual Staging |  | 
|  |
| Scatterplot of gp160 Band Reflectance on DPP Assay vs. Duration of HIV Infection |  | 
|  |
| Scatterplot of gp120 Band Reflectance on DPP Assay vs. Duration of HIV Infection |  | 
|  |
| Sequential Band Evolution on DPP HIV Assay |  | 
|  |
| Evolution of gp160 Band Reflectance in Subtype B vs. C HIV infection, Southern Brazil |  | 
|  |
| Evolution of gp160 Band Reflectance in Subtype B vs. C HIV infection, Southern Brazil |  | 
|  |
| Evolution of gp160 Band Reflectance in Subtype B vs. C HIV infection, Soouthern Brazil |  | 
|  |
| DPP HIV 1/2 Confirmatory Immunoblot (n=237 specimens) |  | 
|  |
| Ricardo da Silva de Souza MD, MHA, PhD |  | 
|  |
|
 |